FilingSEC EDGAR8-K
NeuroOne Completes Successful Large-Animal Procedures Using StereoCED Platform
· SEC accepted
StagePreclinical
Filing content
NeuroOne successfully completed large-animal procedures using its next-generation StereoCED platform for targeted drug delivery and electrophysiological monitoring.
AI summary of the filing. Please also check the source.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…